Style | Citing Format |
---|---|
MLA | Arjmandi K, et al.. "Evaluation of Ts and Enosf1 Variants As a Biomarker in Response to Neoadjuvant Chemotherapy Based on 5Fu in Gastric Cancer Patients." Asian Pacific Journal of Cancer Prevention, vol. 23, no. 9, 2022, pp. 2983-2989. |
APA | Arjmandi K, Ameli F, Salahshourifar I, Esfandbod M, Irani S (2022). Evaluation of Ts and Enosf1 Variants As a Biomarker in Response to Neoadjuvant Chemotherapy Based on 5Fu in Gastric Cancer Patients. Asian Pacific Journal of Cancer Prevention, 23(9), 2983-2989. |
Chicago | Arjmandi K, Ameli F, Salahshourifar I, Esfandbod M, Irani S. "Evaluation of Ts and Enosf1 Variants As a Biomarker in Response to Neoadjuvant Chemotherapy Based on 5Fu in Gastric Cancer Patients." Asian Pacific Journal of Cancer Prevention 23, no. 9 (2022): 2983-2989. |
Harvard | Arjmandi K et al. (2022) 'Evaluation of Ts and Enosf1 Variants As a Biomarker in Response to Neoadjuvant Chemotherapy Based on 5Fu in Gastric Cancer Patients', Asian Pacific Journal of Cancer Prevention, 23(9), pp. 2983-2989. |
Vancouver | Arjmandi K, Ameli F, Salahshourifar I, Esfandbod M, Irani S. Evaluation of Ts and Enosf1 Variants As a Biomarker in Response to Neoadjuvant Chemotherapy Based on 5Fu in Gastric Cancer Patients. Asian Pacific Journal of Cancer Prevention. 2022;23(9):2983-2989. |
BibTex | @article{ author = {Arjmandi K and Ameli F and Salahshourifar I and Esfandbod M and Irani S}, title = {Evaluation of Ts and Enosf1 Variants As a Biomarker in Response to Neoadjuvant Chemotherapy Based on 5Fu in Gastric Cancer Patients}, journal = {Asian Pacific Journal of Cancer Prevention}, volume = {23}, number = {9}, pages = {2983-2989}, year = {2022} } |
RIS | TY - JOUR AU - Arjmandi K AU - Ameli F AU - Salahshourifar I AU - Esfandbod M AU - Irani S TI - Evaluation of Ts and Enosf1 Variants As a Biomarker in Response to Neoadjuvant Chemotherapy Based on 5Fu in Gastric Cancer Patients JO - Asian Pacific Journal of Cancer Prevention VL - 23 IS - 9 SP - 2983 EP - 2989 PY - 2022 ER - |